Paclitaxel Labatec 30 mg/5 ml, solution à diluer pour perfusion
7680602280012
CH-60228
Lösung
Associated product:
PACLITAXEL Labatec 30 mg/5ml flac 5 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.635 G | Substance | HBESI |
|
(N/A)
|
1.925 G | Substance | HBESI |
Reimbursement information
Public price
CHF 39.45
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2010
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 60228
- Drug name
- Paclitaxel Labatec, solution à diluer pour perfusion
- Galenic form
- KOINF
- ATC Code
- L01CD01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 09/04/2010
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- PACLITAXEL Labatec 30 mg/5ml flac 5 ml
- Description (DE)
- PACLITAXEL Labatec 30 mg/5ml Durchstf 5 ml
- Market launch
- 09/04/2010
- Narcotic (BTM)
- No
Original drug
Abraxane, Pulver zur Herstellung einer Infusionsdispersion
GTIN: 7680631820012
CHF 332.10